How to Remove Retained Products of Conception After Abortion

Retained products of conception after an abortion are typically managed through one of three broad approaches: watchful waiting (expectant management), medication to encourage the uterus to expel the remaining tissue, or a procedural intervention to physically remove it. The best path depends on how much tissue remains, whether it has its own blood supply, how heavily you are bleeding, and whether you hope to become pregnant again soon. Each option carries distinct trade-offs in effectiveness, speed, and risk of complications like scarring.

Recognizing That Something Has Been Retained

RPOC, as clinicians abbreviate it, means that tissue from the pregnancy has not been fully expelled or removed. After an abortion, it occurs in a meaningful minority of cases. One retrospective study found the incidence was about 7 percent among patients who had abortive treatment.¹ The most common warning sign is vaginal bleeding that continues or restarts after the procedure, sometimes accompanied by lower abdominal or pelvic pain and foul-smelling discharge if infection sets in.² In one study, vaginal bleeding as a predictor of RPOC had a sensitivity of 93 percent, meaning it catches most true cases, though its specificity was only 50 percent, so plenty of people bleed without having retained tissue.³

Diagnosis is confirmed by ultrasound. The single most reliable finding on imaging is a bright (echogenic) mass inside the uterus, which has the best combination of sensitivity and specificity among the signs clinicians look for.⁴ Endometrial thickness alone is less useful, because the cutoff values vary widely and many people without RPOC also have a thick lining after a recent pregnancy.⁵ Color Doppler, which shows blood flow to the retained tissue, helps stratify bleeding risk rather than diagnose the tissue itself. Combining ultrasound measurements with a blood test for hCG (the pregnancy hormone) improves accuracy considerably, with the paired approach reaching a sensitivity of 93 percent and specificity of 91 percent in a meta-analysis of over 3,200 patients.⁶ However, hCG alone is not a reliable tool for preoperative diagnosis of RPOC; roughly 80 percent of confirmed cases have negative hCG results.⁷

Watching and Waiting

Not every case of RPOC needs an immediate procedure. When the retained tissue is small, you are not bleeding heavily, and the tissue does not have a worrisome blood supply on Doppler, expectant management means giving your body time to pass the remaining material on its own. In one cohort, about three-quarters of patients selected for expectant management recovered without any additional intervention.¹ A large 20-year retrospective study similarly found a success rate around 79 percent for expectant management, with a complication rate of only about 4 percent, which was among the lowest of any treatment approach.⁸

The catch is that resolution takes time. In the Japanese cohort, the retained tissue took a median of about 12 weeks to disappear entirely on ultrasound, with the blood flow to it fading after roughly 7 weeks.¹ The patients most likely to fail expectant management were those who had heavy bleeding at the time of their abortion and those whose retained tissue was highly vascular on Doppler imaging. If you are in that category, your provider will likely recommend acting sooner rather than watching.

Medical Management With Misoprostol

Misoprostol, the same medication used in medical abortions, can be given to stimulate the uterus to contract and expel retained tissue. It is typically placed vaginally, often as four 200-microgram tablets for a total dose of 800 micrograms.⁹ The effectiveness varies quite a bit depending on the clinical situation. In one retrospective cohort, about 65 percent of patients who chose misoprostol for RPOC avoided surgery entirely. But results depended heavily on what the original treatment had been: when the initial miscarriage or abortion had been managed expectantly (without medications or surgery), misoprostol for RPOC worked in about 76 percent of cases, compared with only about 40 to 44 percent when the initial treatment had been medical or surgical.¹⁰

A systematic review that compared medical versus expectant management head-to-head found no significant difference between the two. In the randomized data, about 57 percent of the expectant group and 62 percent of the medical group resolved without needing surgery. In either approach, roughly 60 percent of patients avoided a procedure altogether.¹¹ Misoprostol may be most useful when you want to try something active but prefer to avoid a surgical procedure, understanding that there is roughly a coin-flip chance it will work on its own.

Surgical Removal Options

When expectant and medical management fail or are not appropriate, procedural options range from simple and fast to more targeted and specialized. The choice matters for both immediate effectiveness and long-term consequences like uterine scarring.

Dilation and Curettage or Vacuum Aspiration

Traditional dilation and curettage (D&C) involves dilating the cervix and scraping or suctioning out the uterine contents. It has been the standard surgical approach for decades and achieves complete evacuation in the vast majority of cases. Manual vacuum aspiration (MVA) is a variation that uses a handheld syringe-generated vacuum instead of electric suction or a curette. A comparative trial found MVA had an efficacy of 98 percent versus 94 percent for conventional evacuation, with the added advantage of shorter operating time, shorter hospital stays, and the ability to perform the procedure under local anesthesia rather than general sedation.¹²

In the 20-year tertiary-center study, D&C had a success rate of about 94 percent but also had a complication rate of around 16 percent, higher than either expectant management or hysteroscopic surgery.⁸ The main worry is that blind curettage injures the basal layer of the endometrium (the deeper tissue lining the uterus), which can lead to intrauterine adhesions, commonly known as Asherman syndrome.

Hysteroscopic Removal

Hysteroscopy involves inserting a thin camera through the cervix so the surgeon can see exactly what is inside the uterus and remove the retained tissue under direct vision. This targeted approach avoids the blind scraping of traditional curettage. In the same 20-year study, hysteroscopic surgery had the highest success rate at about 97 percent and the lowest complication rate at just over 1 percent.⁸

Within hysteroscopy, there are different tools for actually removing the tissue. A multicenter randomized trial compared hysteroscopic morcellation (a device that simultaneously cuts and suctions tissue) with electric vacuum aspiration performed under hysteroscopic guidance. Morcellation achieved complete removal in about 95 percent of patients versus 83 percent for vacuum aspiration, and fewer patients in the morcellation group needed a follow-up procedure.¹³ Complication rates were low and similar between the two, though morcellation took slightly longer (about 7 minutes versus about 6 minutes for vacuum aspiration).

One other study that used operative hysteroscopy to remove RPOC achieved complete evacuation in all patients, with subsequent second-look hysteroscopy revealing no adhesions in any of the 21 patients checked.¹⁴ The evidence consistently points toward hysteroscopy as the approach most likely to clear the tissue completely while minimizing the risk of uterine scarring.

The Scarring Question

Intrauterine adhesions are a major concern for anyone who wants to become pregnant in the future. Scar tissue inside the uterus can interfere with implantation and normal menstruation. The risk depends on what type of procedure is done, how many times it has been done, and on individual biology.

In the multicenter hysteroscopy trial, intrauterine adhesions were found in about 14 percent of patients after morcellation and about 21 percent after vacuum aspiration at follow-up, and neither rate was dramatically different from the other.¹³ Curettage of a recently pregnant uterus is a well-recognized trigger for adhesion formation.¹⁵ The risk climbs steeply with repeat procedures. A study of women who had either a secondary removal of placental remnants or a repeat curettage for incomplete abortion found intrauterine adhesions in 40 percent of patients at a follow-up hysteroscopy three months later, with those who developed menstrual problems having a 12-fold increased risk of moderate-to-severe adhesions.¹⁶

On the other hand, a large study of over 2,500 women who had post-abortion uterine curettage found an overall incidence of Asherman syndrome of 1.6 percent, with a history of three or more prior abortions raising the risk by about 4.6 times. Interestingly, this study found that the type of instrument used (vacuum versus sharp curette) did not independently predict adhesion risk.¹⁷ The discrepancy in adhesion rates across studies likely reflects differences in how hard clinicians looked for adhesions (routine follow-up hysteroscopy catches subclinical scarring that would otherwise go unnoticed) and differences in patient populations. The takeaway is that first-time procedures carry a relatively modest adhesion risk, but repeat curettage dramatically escalates it.

There is also research interest in whether treating RPOC with hysteroscopy rather than curettage reduces the chance of adhesions recurring if RPOC happens again. One study found that initial treatment by suction curettage was associated with a roughly 3.6-fold higher odds of recurrent RPOC compared with hysteroscopy.¹⁸

When the Tissue Has Its Own Blood Supply

Some retained tissue develops a significant vascular network, sometimes including large arteriovenous shunts that essentially short-circuit blood flow. These hypervascular cases are dangerous because a standard D&C can trigger life-threatening hemorrhage.¹⁹ RPOC with marked vascularity occurs after abortion in the majority of reported cases. One series found that 87 percent of hypervascular RPOC cases followed an abortion rather than a delivery.²⁰

The main treatment for hypervascular RPOC is uterine artery embolization (UAE), a radiology procedure that threads a catheter through the groin into the uterine arteries and blocks the blood vessels feeding the tissue. In that same series, a single embolization resolved the problem in about 74 percent of patients, and overall 87 percent were managed by embolization alone without needing surgery. Some patients with large arteriovenous shunts required multiple procedures or, in two cases, ultimately a hysterectomy.²⁰ A common two-step strategy is to perform embolization first to cut off the blood supply, then do curettage or hysteroscopy a few days later once Doppler confirms the vascularity has dropped.¹⁹

Infection and Antibiotic Use

Retained tissue can become a breeding ground for bacteria. When infection complicates an abortion with retained products, it is classified as a septic abortion, and the mainstay of treatment is broad-spectrum antibiotics combined with evacuation of the retained tissue.²¹ Whether routine prophylactic antibiotics should be given before surgical removal in the absence of active infection is less settled. A narrative review of the available literature concluded that evidence for antibiotic prophylaxis reducing pelvic infection after surgical removal of RPOC is limited.²² In practice, many clinicians do give a single prophylactic dose because the potential benefit is meaningful and the risk of one dose is low, but the evidence base does not strongly demand it.

Office-Based Hysteroscopy Without General Anesthesia

One practical barrier to hysteroscopic removal is that it has traditionally been performed in an operating room under general anesthesia or sedation. A growing body of work shows it can be done safely in an office or outpatient clinic setting without anesthesia or with only local anesthesia. In a series of 101 patients, office hysteroscopy for RPOC was completed successfully in 93 percent, with a mean procedure time of 18 minutes and a mean patient-reported pain score of just 2.3 out of 10.²³ A larger series of 163 patients had a 95 percent complete-removal rate without complications when the procedure was performed in an office setting without anesthesia, though about 7 percent of cases were not attempted in the office because the physician judged the tissue too vascular or the patient experienced too much pain during the initial diagnostic look.²⁴

Office-based procedures reduce cost, avoid the risks of general anesthesia, and let patients go home sooner. They are not suitable for everyone, particularly if the RPOC is large, highly vascular, or if the patient has a low tolerance for the cramping that accompanies the procedure. But for straightforward cases, the data suggests this approach is safe and well-tolerated.

Fertility After RPOC Treatment

If you are hoping to conceive again, the method used to remove retained tissue matters. After hysteroscopic removal, reproductive outcomes look encouraging. In one study comparing hysteroscopic morcellation with loop resection, the live birth rate was about 89 percent in the morcellation group and 68 percent in the loop resection group, with a median time to pregnancy of about 14 to 15 weeks in both groups.²⁵ The operative hysteroscopy study that performed second-look procedures found a conception rate of 82 percent among women who wanted to become pregnant, with a live birth rate of 75 percent and, critically, no adhesions on follow-up.¹⁴

A systematic review that tried to compare how different RPOC treatment options affect future fertility concluded that there is not yet enough evidence to declare one approach definitively better for reproductive outcomes.²⁶ Anti-adhesion barrier gels, sometimes applied during hysteroscopy to prevent scarring, also did not show a statistically significant benefit in the limited data available. The research is still catching up, but the trend in the literature favors hysteroscopy over blind curettage for patients whose future fertility is a priority.

How Follow-Up Is Typically Handled

After any treatment for RPOC, clinicians usually schedule a follow-up ultrasound to confirm that the tissue has cleared. A scoping review found enormous variation in how and when follow-up happens, but the most common timing was around two weeks after treatment.²⁷ The most frequently used ultrasound criterion for judging success was an endometrial thickness below 15 mm, though the same review noted that there is no universally agreed-upon cutoff. If you are being managed expectantly, follow-up windows can stretch longer, sometimes with serial scans over several weeks.

An emerging nonsurgical approach worth noting is the use of oral estrogen-progestogen therapy (such as Femoston) to help the endometrium remodel and shed retained tissue. A prospective comparative study of 75 women found that this hormonal approach was associated with shorter bleeding duration, earlier return of normal menstruation, and a lower rate of adverse outcomes including infection and adhesions compared with hysteroscopic evacuation, though hysteroscopy achieved a higher immediate clearance rate.²⁸ This is a relatively new finding and not yet widely adopted, but it signals growing interest in noninvasive alternatives.

Choosing Between Approaches

No single treatment is right for every case of RPOC, and the decision often comes down to a few practical considerations:

Size and vascularity: Small, non-vascular retained tissue is a good candidate for expectant or medical management. Large or hypervascular tissue usually needs a procedure, sometimes preceded by embolization.
Bleeding severity: If you are bleeding heavily or showing signs of infection, waiting is generally not safe. Surgical evacuation combined with antibiotics if needed becomes the priority.
Future fertility goals: If preserving your ability to conceive is important, hysteroscopic removal appears to carry the least adhesion risk, particularly compared with repeat blind curettage.
Access and resources: Hysteroscopy requires trained surgeons and equipment that may not be available everywhere. Manual vacuum aspiration under local anesthesia is a practical, effective alternative in settings with fewer resources.
Tolerance for uncertainty: Expectant management works for most properly selected patients, but it means living with weeks of spotting and repeated ultrasound visits. Some people would rather have a definitive procedure and move on.

Your provider should discuss these trade-offs with you. If you are offered a blind D&C and future fertility matters to you, it is reasonable to ask whether hysteroscopic removal is available. If you are stable and the retained tissue is small, asking about expectant management is equally reasonable. The evidence suggests all of these approaches work, but they do not all carry the same risk of long-term consequences.

1
European Journal of Obstetrics & Gynecology and Reproductive Biology. Expectant management of retained products of conception following abortion: A retrospective cohort study
2
PubMed Central. Retained Products of Conception (RPOC): Diagnosis, Complication & Management
3
PubMed. Role of clinical and ultrasound findings in the diagnosis of retained products of conception
4
American Journal of Obstetrics & Gynecology. Sonographic accuracy of detection of retained products of conception
5
PubMed Central. Ultrasound Assessment of Retained Products of Conception (RPOC): Insights from the Current Literature
6
PubMed. Diagnostic accuracy of transvaginal ultrasound-measured endometrial thickness and serum hCG levels in detecting retained products of conception: a systematic review and meta-analysis
7
PubMed. Serum β-HCG Level in Women Diagnosed as Having Retained Products Of Conception: A Prospective Cohort Study
8
PubMed Central. Management of retained products of conception in a tertiary centre: a 20-year retrospective cohort study
9
PubMed Central. Sonographic Predictors and Outcomes of Second-Dose Misoprostol in Early Pregnancy Loss
10
PubMed. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study
11
Journal of Endometriosis and Uterine Disorders. Medical versus expectant management for retained products of conception after initial treatment for early pregnancy loss or induced abortion, a systematic review
12
Annals of Pakistan Institute of Medical Sciences. Comparison of Manual Vacuum Aspiration Versus Conventional Evacuation of Retained Products
13
Fertility and Sterility. Hysteroscopic Morcellation vs Electric Vacuum Aspiration for the Removal of Retained Products of Conception: A Multicenter Randomized Controlled Trial
14
ScienceDirect. Operative Hysteroscopy to Remove Retained Products of Conception: Novel Treatment of an Old Problem
15
PubMed Central. Asherman’s syndrome: current perspectives on diagnosis and management
16
Human Reproduction. Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion
17
PubMed. Identifying the risk factors and incidence of Asherman Syndrome in women with post-abortion uterine curettage
18
European Journal of Obstetrics & Gynecology and Reproductive Biology. Retained products of conception: What is the risk for recurrence on subsequent pregnancies?
19
PubMed. Management of retained products of conception with marked vascularity
20
PubMed. Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment
21
PubMed Central. Antibiotics for treating septic abortion
22
Journal of Women Health Care and Issues. Usefulness of Antibiotic Prophylaxis in Miscarriage Surgery for Induced Abortion and Retained Products of Conception: a Narrative Review
23
PubMed. Office hysteroscopy in removing retained products of conception – a highly successful approach with minimal complications
24
PubMed. Hysteroscopic Treatment of Retained Products of Conception Using See and Treat Operative Office Hysteroscopy Without Anesthesia
25
Journal of Minimally Invasive Gynecology. Reproductive and Obstetric Outcomes After Hysteroscopic Removal of Retained Products of Conception
26
Gynecological Surgery. Fertility outcome after treatment of retained products of conception: a systematic review
27
PubMed Central. Diagnostic criteria for retained products of conception-A scoping review
28
Wiley Online Library (J Obstet Gynaecol Res). Comparative Efficacy of Hysteroscopic Evacuation Versus Oral Estrogen-Progestogen Therapy (Femoston) for Retained Products of Conception After Abortion: A Prospective Comparative Study